共 50 条
International differences in drug prices
被引:37
|作者:
Wagner, JL
[1
]
McCarthy, E
[1
]
机构:
[1] Inst Med, Washington, DC 20001 USA
关键词:
prescription drugs;
price discrimination;
pharmaceutical research and development;
drug price regulation;
D O I:
10.1146/annurev.publhealth.25.101802.123042
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
This paper addresses how and why drug prices differ across countries. Studies of international variation in drug prices reach varied conclusions owing to methodological and data disparities. Price differences do exist across countries, with the United States footing the highest bill, but the differences are not nearly as large as they appear at first glance. The higher prices in the United States are concentrated among a subset of brandname drugs and among those without insurance covering drugs. Some U.S. health plans obtain price concessions from manufacturers similar to those obtained by national governments. Price concessions occur whenever purchasers are willing to let price be a consideration in decisions about access and utilization. In low-income countries the vast majority are unwilling to pay for effective drugs simply because they are unable to pay. Low-income nations need more price discrimination-and vastly lower prices-if they are ever to afford the world's most effective medicines.
引用
收藏
页码:475 / 495
页数:21
相关论文